Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Highlow study
2012-001505-24Phase 4Completed
- Sponsor
- Academic Medical Center
- Start
- Nov 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of nadroparin in venous thromboembolism (VTE) and deep vein thrombosis (DVT) (2 arms), sponsored by Academic Medical Center. Primary endpoint: Recurrent VTE. Started Nov 2012; status: completed.
02
Drugs
nadroparin
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2012-001505-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001505-24.